Pressure ulcers are serious and common medical conditions in U.S. nursing homes. Pressure ulcers, also known as decubitus, will remain an important public health problem with the rise in aging population. The CDC reports that 11% of nursing home residents had pressure ulcers in 2004. Various demographic and clinical factors were related to having a pressure ulcer in a nursing home. Residents in a nursing home for a year or less since admission, who had a recent weight loss, or who had high immobility had the highest prevalence of pressure ulcers. Among residents with a pressure ulcer of stage 2 or higher, 35% received special wound care services.
This data suggests that a minority of nursing home residents with stage 2 or higher pressure ulcers received wound care in accordance with the clinical practice guidelines but is it enough? How are our healthcare researching preparing for the need for better wound care? We have developed a transdermal spray that is proven to support enhanced healing of decubitus and wounds in general. Here is a powerpoint with the voiceover by the gentleman the suffered the wound. He is 72 years old and sufferd a fall that required 10 stitches. His immediate use of the csmartskin wound care product greatly enhanced the healing, lack of infection and lack of scar that he experienced:
Information from the CDC Data Brief on pressure ulcer prevalence among nursing home residents may provide a foundation for targeting public health efforts. Wound care as an area of clinical study and research needs be receiving increasing attention to keep up with the anticipated increased need due to high frequency of pressure ulcers that will be occurring with the rise in an aging population.
According to webMD and John’s Hopkins the state of the art recommendation to treat 2nd degree burns is to use soap or a cleanser and water and an antibiotic ointment. 2nd burns are the same burn you would receive if you went to a dermatolagist or a plastic surgeon to have a glycolic acid peel or a laser peel and typically take months to heal.
Wow that seems unbelievable. With all due respect it is hard to believe that recommended state of the art in burn treatment is soap and water and Bacitracin with all the scientists out there spending billions of dollars on research.
csmartskin has figured out a way to go beyond soap, water and antibiotic ointment to treat burns. csmartskin’s transdermal spray enhances healing by supporting the skin to uber-heal itself by turning on the turbo-thrusters of nerve activity and nourishing the skin with nutrients.
Below is a ppt depicting the burn protocol for a patient that had 3rd degree burns over 65% of his body from a gasoline fire. He was treated at the Nassau county Fireman’s Burn Hospital for 6 months. The cost of treatment totaled $940,000. The next step in their treatment plan was to amputate because the burns on his legs had not healed sufficiently to save them after the $940,000 of treatment costs. Within 6 weeks of using csmartskin’s transdermal spray for burns the skin on his legs was almost completely healed.
Here are before and after pics of the burn protocol:
There are several acne treatment products that are highly advertised that are based on benzyl peroxide. To name a few pro-active, clearasil, and others.
A quick search on the internet about the effectiveness of these products shows varied opinions about the effectiveness of these products. Several cite the need to continue to stay on the product continuously for it to work. Other opinions cite the known side effect of dryness.
csmartcorp develops products to enhance healing from burns and wounds and to treat pain. It turns out that the same science that has gone into the products that treat more serious skin ailments such as burns and wounds works really well on acne. The scientific approach is to support the skin’s own ability to heal itself . That approach is effective whether the skin is insulted by a burn, wound, skin lupus, decubitus, cellulitis or neuropathy or acne.
For acne sufferers this is good news. The science behind products that heal skin from serious ailments turns out to be highly effective in treating acne, scars and uneven skin tone. In fact, csmartskin Clarify Acne Treatment product has been clinically tested to show that 100% of the people who use it see an improvement in 2 weeks in breakouts, scar reduction, evenness of color and skin tone. This is a clear example that skin is skin, and the csmartcorp products simply support the skin in healing whatever the ailment.
Here are some before and after pics of clients that suffer from acne and quickly saw visible results:
Aging athletes face the very real threat of arthritis from years of training. Kristin Armstrong who won her second gold medal at the London 2012 Olympics at age 38, is one of them even though she was diagnosed in 2001 with osteoarthritis, a degeneration of cartilage in both of her hip joints. Other well-known athletes afflicted with arthritis during their competitive years include Shaquille O’Neal, golfer Kristy McPherson, Olympic gold medal winning ice skater Dorothy Hamill, Jack Nicklaus, Hank Aaron, Joe Namath, and Nolan Ryan.
The old thinking in arthritis treatment which has resulted in drugs like Enbrel, marketed by Pfizer and Amgen, is flawed from the get-go.
Our transdermal spray “pain care complete” was originally created in 2004 to modulate inflammation, pain and re-myelination in an individual afflicted with Guillain-Barre Syndrome and is also efficacious with use for Osteoarthritis, Rheumatoid arthritis, Psoriatic arthritis and the four types of peripheral neuropathies.
We recently published the journal article below explaining our approach to arthritis treatment which is innovative and represents out of the box thinking.
Pfizer and Johnson & Johnson recently concluded and announced on July 23rd, 2012 results of Phase 3 of the clinical trial on a jointly developed drug bapineuzumab. The closely watched experimental treatment for Alzheimer’s disease proved ineffective in its first large clinical trial. This utter failure completely debunked a theory about the cause of the disease. One of the principal investigators in the study, Dr. Reisa Sperling, stated “there was no sign of any effect.”
Having researched this in the past, it seemed clear to us that this drug would fail. It does not seem to recognize the pathways that are obvious to us. Here is a paper that I wrote and published on slideshare that breaks down our thinking on pathways and causation of Alzheimer’s disease.